Product

SAGE 217

Aliases

SAGE 217 30 mg Capsules

1 clinical trial

1 indication

Indication

Postpartum Depression

Clinical trial

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-217 in the Treatment of Adult Female Subjects With Severe Postpartum Depression

Status: Completed, Estimated PCD: 2018-11-15